Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Bone marrow endothelial progenitors in atherosclerotic plaque resolution.

Yao L, Heuser-Baker J, Herlea-Pana O, Barlic-Dicen J.

Organogenesis. 2013 Jan-Mar;9(1):29-33. doi: 10.4161/org.24433. Epub 2013 Jan 1.

2.

Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering.

Yao L, Heuser-Baker J, Herlea-Pana O, Iida R, Wang Q, Zou MH, Barlic-Dicen J.

Stem Cells. 2012 Dec;30(12):2720-31. doi: 10.1002/stem.1256.

3.

Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression.

Herlea-Pana O, Yao L, Heuser-Baker J, Wang Q, Wang Q, Georgescu C, Zou MH, Barlic-Dicen J.

Cardiovasc Res. 2015 May 1;106(2):324-37. doi: 10.1093/cvr/cvv111. Epub 2015 Mar 12.

4.

Ambivalence of progenitor cells in vascular repair and plaque stability.

Hristov M, Weber C.

Curr Opin Lipidol. 2008 Oct;19(5):491-7. doi: 10.1097/MOL.0b013e32830dfe33. Review.

PMID:
18769230
5.

Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.

Harada N, Ito K, Hosoya T, Mimura J, Maruyama A, Noguchi N, Yagami K, Morito N, Takahashi S, Maher JM, Yamamoto M, Itoh K.

Free Radic Biol Med. 2012 Dec 15;53(12):2256-62. doi: 10.1016/j.freeradbiomed.2012.10.001. Epub 2012 Oct 7.

PMID:
23051009
6.

Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.

Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.

7.

Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?

Werner N, Nickenig G.

Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):257-66. Epub 2005 Dec 1. Review.

8.

[Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].

Sertić J, Skorić B, Lovrić J, Bozina T, Reiner Z.

Acta Med Croatica. 2010 Oct;64(4):237-45. Review. Croatian.

PMID:
21688606
9.

The importance of reendothelialization after arterial injury.

Versari D, Lerman LO, Lerman A.

Curr Pharm Des. 2007;13(17):1811-24. Review.

PMID:
17584110
10.

A novel hypothesis of atherosclerosis: EPCs-mediated repair-to-injury.

Zhang M, Zhou SH, Li XP, Shen XQ, Fang ZF.

Med Hypotheses. 2008;70(4):838-41. Epub 2007 Oct 24.

PMID:
17920780
11.

Low-density lipoprotein apheresis: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(5):1-101. Epub 2006 Nov 1.

12.

Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.

van der Stoep M, Li Z, Calpe-Berdiel L, van der Sluis RJ, Saleh P, McKinnon HJ, Smit MJ, Korporaal SJ, Van Berkel TJ, Van Eck M, Hoekstra M.

Biochem Pharmacol. 2013 Dec 1;86(11):1594-602. doi: 10.1016/j.bcp.2013.09.019. Epub 2013 Oct 2.

PMID:
24095721
13.

The effect of statins on high-risk atherosclerotic plaque associated with low endothelial shear stress.

Takahashi S, Papafaklis MI, Sakamoto S, Antoniadis AP, Coskun AU, Feldman CL, Stone PH.

Curr Opin Lipidol. 2011 Oct;22(5):358-64. doi: 10.1097/MOL.0b013e32834ab106. Review.

PMID:
21841484
14.

[Pathology of AtheroThrombosIS (ATIS)].

Ueda M.

Drugs. 2010 Nov 1;70 Suppl 1:3-8. doi: 10.2165/00000004-000000000-00000. Review. Japanese.

PMID:
20977286
15.

Identifying the vulnerable patient with rupture-prone plaque.

Weintraub HS.

Am J Cardiol. 2008 Jun 16;101(12A):3F-10F. doi: 10.1016/j.amjcard.2008.04.013.

PMID:
18549869
16.

Id1: a novel therapeutic target for patients with atherosclerotic plaque rupture.

Wang G, Qiu J, Hu J, Tang C, Yin T.

Med Hypotheses. 2011 May;76(5):627-8. doi: 10.1016/j.mehy.2011.01.014. Epub 2011 Feb 1.

PMID:
21288647
17.

Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.

Ylä-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R, Kwak BR, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PW, Waltenberger J, Weber C, Tokgözoglu L.

Thromb Haemost. 2011 Jul;106(1):1-19. doi: 10.1160/TH10-12-0784. Epub 2011 Jun 14. Review.

PMID:
21670845
18.

Vaccines against atherosclerosis.

Nilsson J, Wigren M, Shah PK.

Expert Rev Vaccines. 2013 Mar;12(3):311-21. doi: 10.1586/erv.13.4. Review.

PMID:
23496670
19.

CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.

Akhtar S, Gremse F, Kiessling F, Weber C, Schober A.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):679-86. doi: 10.1161/ATVBAHA.112.301162. Epub 2013 Feb 7. Erratum in: Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):e125.

20.

Myocardial infarction accelerates atherosclerosis.

Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, Iwamoto Y, Thompson B, Carlson AL, Heidt T, Majmudar MD, Lasitschka F, Etzrodt M, Waterman P, Waring MT, Chicoine AT, van der Laan AM, Niessen HW, Piek JJ, Rubin BB, Butany J, Stone JR, Katus HA, Murphy SA, Morrow DA, Sabatine MS, Vinegoni C, Moskowitz MA, Pittet MJ, Libby P, Lin CP, Swirski FK, Weissleder R, Nahrendorf M.

Nature. 2012 Jul 19;487(7407):325-9. doi: 10.1038/nature11260.

Items per page

Supplemental Content

Write to the Help Desk